Press Releases
Hogan Lovells secures FDA emergency use authorization for Lucira Health for breakthrough OTC COVID-19 and flu test
07 March 2023
PartnerDenver
Email [email protected]hoganlovells.com
Phone +1 303 454 2463
Fax +1 303 899 7333
Practice groupGlobal Regulatory
Jodi Scott developed and honed her practical, real-world sensibility and business acumen during the time she spent as an in-house FDA counsel with Medtronic PLC, the world's largest medical device manufacturer.
Today, she uses that background to solve the challenges that confront her clients in areas that include MDRs, regulatory due diligence, importing and exporting medical devices, advertising and promotion, preparing for and managing FDA inspections, developing systems to mitigate the risks associated with the unapproved use of approved products (AKA off-label uses), developing digital health technology, and securing the necessary state medical device manufacturer and distributor licenses.
Jodi assists the medical device industry in navigating the complex requirements so as to maintain compliance with the U.S. Food and Drug Administration's (FDA) quality system (QSR) and other post-market regulatory rules. She spends much of her time developing and implementing strategies to manage FDA-initiated enforcement actions, such as FDA inspections that result in FDA Form 483s, untitled letters, Warning Letters, investigations, and consent degrees of permanent injunction. She has received ISO 13485 auditor certification and assists companies in preparing for managing and responding to ISO and MDSAP audits.
She also guides her clients through complex medical device recalls by helping them work through the difficult decisions of whether a recall is warranted and, if so, how to execute it in a way that best achieves a balance between patient and customer risk and the agency's interests, while also demonstrating the company's commitment to safety and its regulatory obligations.
She also applies her regulatory knowledge in assisting clients with regulatory due diligence related to mergers and acquisitions and funding, such as private equity deals, initial public offerings, and other financial transactions.
Jodi co-leads the firm’s cross-functional Digital Health Working Group and regularly assists clients in navigating the complexities of FDA regulation of digital health technologies with an eye to helping them meet their business objectives while being mindful of the potential for regulatory obligations.
Outstanding Women in Business, Law
Denver Business Journal
Life Sciences Star
LMG Life Sciences
Leading Life Sciences Lawyer
LMG Life Sciences
Lawyer of the Year
Law Week Colorado
Best Life Science Lawyer - Colorado
The Corporate America M&A Awards
Education
J.D., The Catholic University of America, Columbus School of Law, cum laude, 1998
B.S., Drake University College of Pharmacy and Health Sciences, 1995
Memberships
Board Member, Colorado BioScience Association
Contributing Expert to FDANews Inspection Insider
Food & Drug Law Institute
Bar admissions and qualifications
Colorado
District of Columbia
ISO 13485 Certified Auditor
Press Releases
07 March 2023
Hogan Lovells Podcasts
17 February 2023
News
02 February 2023
News
10 January 2023
Sponsorships and Speaking Engagements
9-12 January 2023
News
04 January 2023